Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVAR RediHaler in Persistent Asthma
NCT02040779Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in persistent asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2013; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
persistent asthma
Beyond the preview
Go deeper on NCT02040779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040779.